Waters... noitazilaicremmoC dna tnempole

2025-06-13 12:03:37Nav：SpotlightViews (8)

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists